BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 23475416)

  • 1. Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals.
    Moon HS; Dalamaga M; Kim SY; Polyzos SA; Hamnvik OP; Magkos F; Paruthi J; Mantzoros CS
    Endocr Rev; 2013 Jun; 34(3):377-412. PubMed ID: 23475416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin in relation to the lipodystrophy-associated metabolic syndrome.
    Mantzoros CS
    Diabetes Metab J; 2012 Jun; 36(3):181-9. PubMed ID: 22737657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin in congenital and HIV-associated lipodystrophy.
    Tsoukas MA; Farr OM; Mantzoros CS
    Metabolism; 2015 Jan; 64(1):47-59. PubMed ID: 25267014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy resistant diabetes mellitus and lipodystrophy: leptin therapy leads to improvement].
    Jazet IM; Jonker JT; Wijngaarden MA; Lamb H; Smelt AH
    Ned Tijdschr Geneeskd; 2013; 157(4):A5482. PubMed ID: 23343738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipokines in the HIV/HAART-associated lipodystrophy syndrome.
    Paruthi J; Gill N; Mantzoros CS
    Metabolism; 2013 Sep; 62(9):1199-205. PubMed ID: 23706880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy.
    Lee JH; Chan JL; Sourlas E; Raptopoulos V; Mantzoros CS
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2605-11. PubMed ID: 16636130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin action in the ventromedial hypothalamic nucleus is sufficient, but not necessary, to normalize diabetic hyperglycemia.
    Meek TH; Matsen ME; Dorfman MD; Guyenet SJ; Damian V; Nguyen HT; Taborsky GJ; Morton GJ
    Endocrinology; 2013 Sep; 154(9):3067-76. PubMed ID: 23782941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipocyte-derived hormone levels in HIV lipodystrophy.
    Kosmiski L; Kuritzkes D; Lichtenstein K; Eckel R
    Antivir Ther; 2003 Feb; 8(1):9-15. PubMed ID: 12713059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART).
    Vigouroux C; Gharakhanian S; Salhi Y; Nguyen TH; Chevenne D; Capeau J; Rozenbaum W
    Diabetes Metab; 1999 Sep; 25(3):225-32. PubMed ID: 10499191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy.
    Vigouroux C; Maachi M; Nguyên TH; Coussieu C; Gharakhanian S; Funahashi T; Matsuzawa Y; Shimomura I; Rozenbaum W; Capeau J; Bastard JP
    AIDS; 2003 Jul; 17(10):1503-11. PubMed ID: 12824788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin ameliorates insulin resistance and hepatic steatosis in Agpat2-/- lipodystrophic mice independent of hepatocyte leptin receptors.
    Cortés VA; Cautivo KM; Rong S; Garg A; Horton JD; Agarwal AK
    J Lipid Res; 2014 Feb; 55(2):276-88. PubMed ID: 24293639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin replacement therapy does not improve the abnormal lipid kinetics of hypoleptinemic patients with HIV-associated lipodystrophy syndrome.
    Sekhar RV; Jahoor F; Iyer D; Guthikonda A; Paranilam J; Elhaj F; Coraza I; Balasubramanyam A
    Metabolism; 2012 Oct; 61(10):1395-403. PubMed ID: 22542724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leptin replacement improves postprandial glycemia and insulin sensitivity in human immunodeficiency virus-infected lipoatrophic men treated with pioglitazone: a pilot study.
    Magkos F; Brennan A; Sweeney L; Kang ES; Doweiko J; Karchmer AW; Mantzoros CS
    Metabolism; 2011 Jul; 60(7):1045-9. PubMed ID: 21081243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of generalized lipodystrophy-associated progeroid syndrome treated by leptin replacement with short and long-term monitoring of the metabolic and endocrine profiles.
    Fukaishi T; Minami I; Masuda S; Miyachi Y; Tsujimoto K; Izumiyama H; Hashimoto K; Yoshida M; Takahashi S; Kashimada K; Morio T; Kosaki K; Maezawa Y; Yokote K; Yoshimoto T; Yamada T
    Endocr J; 2020 Feb; 67(2):211-218. PubMed ID: 31708526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of ghrelin and leptin in the regulation of carbohydrate metabolism. Part II. Leptin.
    Otto-Buczkowska E; Chobot A
    Postepy Hig Med Dosw (Online); 2012 Oct; 66():799-803. PubMed ID: 23175334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-cell dysfunction and low insulin clearance in insulin-resistant human immunodeficiency virus (HIV)-infected patients with lipodystrophy.
    Haugaard SB; Andersen O; Vølund A; Hansen BR; Iversen J; Andersen UB; Nielsen JO; Madsbad S
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):354-61. PubMed ID: 15730419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced Endothelial Leptin Signaling Increases Vascular Adrenergic Reactivity in a Mouse Model of Congenital Generalized Lipodystrophy.
    Bruder-Nascimento T; Kress TC; Pearson M; Chen W; Kennard S; Belin de Chantemèle EJ
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromes.
    Vatier C; Fetita S; Boudou P; Tchankou C; Deville L; Riveline J; Young J; Mathivon L; Travert F; Morin D; Cahen J; Lascols O; Andreelli F; Reznik Y; Mongeois E; Madelaine I; Vantyghem M; Gautier J; Vigouroux C
    Diabetes Obes Metab; 2016 Jul; 18(7):693-7. PubMed ID: 26584826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiency.
    Altarejos JY; Pangilinan J; Podgrabinska S; Akinci B; Foss-Freitas M; Neidert AH; Ray Y; Zheng W; Kim S; Kamat V; Huang M; Min S; Mastaitis J; Dominguez-Gutierrez G; Kim JH; Stevis P; Huang T; Zambrowicz B; Olson WC; Godin S; Bradley E; Gewitz AD; Baker M; Hench R; Davenport MS; Chenevert TL; DiPaola F; Yancopoulos GD; Murphy AJ; Herman GA; Musser BJ; Dansky H; Harp J; Gromada J; Sleeman MW; Oral EA; Olenchock BA
    Sci Transl Med; 2023 Nov; 15(723):eadd4897. PubMed ID: 37992152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metreleptin for injection to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy.
    Meehan CA; Cochran E; Kassai A; Brown RJ; Gorden P
    Expert Rev Clin Pharmacol; 2016; 9(1):59-68. PubMed ID: 26465174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.